Patents by Inventor John Mulliken

John Mulliken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
    Patent number: 6117444
    Abstract: A resorbable hemostatic agent comprising a delivery component, that aids in the delivery to the wound site, and a microfibrillar hemostatic component that controls bleeding in solid tissue and does not delay or interfere with healing is described. The viscosity of this resorbable hemostatic agent can be changed to allow for easy application at a range of temperatures. The resorbable hemostatic agent of the invention provides a biodegradable, biocompatable hemostatic agent which effectively controls bleeding in bone and other dense tissue without interfering with the subsequent healing of the tissue.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: September 12, 2000
    Assignee: Brigham & Women's Hospital
    Inventors: Dennis P. Orgill, John Mulliken, Frederick W. Ehret